Cardiff Lexington Corporation
Cardiff Lexington Corporation
Your view on CDIX
Overview
What the company does, where it operates, and who runs it.
About Cardiff Lexington Corporation
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Alex Hunt Cunningham
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Alex Hunt Cunningham
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
Cardiff Lexington Corporation, together with its subsidiaries, provides affordable housing and tax resolution services in the United States. It also leases and sells mobile homes and mobile home parks, as well as offers an alternative to traditional housing.
The company provides tax resolution bookkeeping, and tax preparation service to individuals and companies that have federal and state tax liabilities. It also engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018.
Cardiff Lexington Corporation was incorporated in 2001 and is headquartered in Fort Lauderdale, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Cardiff Lexington Corporation, and the rating behind it. CDIX last traded at $4.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Cardiff Lexington Corporation. Starting points for Cardiff Lexington Corporation: EPS -$0.68, beta 1.57 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Cardiff Lexington Corporation. Cardiff Lexington Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Cardiff Lexington Corporation. Trailing twelve-month EPS for Cardiff Lexington Corporation stands at -$0.68. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Cardiff Lexington Corporation. Cardiff Lexington Corporation has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Cardiff Lexington Corporation valued side by side against its closest peers. Cardiff Lexington Corporation is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Cardiff Lexington Corporation, and how their positions are changing. At a $26.7M market value, institutional positions materially move Cardiff Lexington Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Cardiff Lexington Corporation executives and directors. Shares of Cardiff Lexington Corporation have traded between $1.30 and $14.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Cardiff Lexington Corporation. Cardiff Lexington Corporation is a $26.7M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Cardiff Lexington Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Cardiff Lexington Corporation. Coverage tracks Cardiff Lexington Corporation within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.